Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-27
1998-05-26
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530350, 530363, 530364, 530825, A61K 3800, C07K 100
Patent
active
057564680
ABSTRACT:
Lyophilized pharmaceutical compositions containing botulinum toxin or botulinum neurotoxin and effective amounts of trehalose and methionine have a shelf life of up to 4 months or more at room temperature and above.
REFERENCES:
patent: 5512547 (1996-04-01), Johnson et al.
Goodnough et al, Applied & Environmental Microbiology, vol. 58, No. 10, pp. 3426-3428, 1992.
Schantz & Johnson, "Properties and Use of Botulinum Toxin and Other Microbial Neurotoxins in Medicine", Mar. 1992, pp. 80-99.
Schantz & Johnson, "Preparation and Characterization of Botulinum Toxin Type A for Human Treatment", vol. 25, pp. 41-49, 94.
Goodnough & Johnson, "Stabilization of Clostridium Botulinum Neurotoxin During Lyophilization", Applied & Environmental Microbiology, Oct. 1992, pp. 3426-3428.
Goodnough Michael C.
Johnson Eric A.
Mohamed Abdel A.
Tsang Cecilia J.
Wisconsin Alumni Research Foundation
LandOfFree
Pharmaceutical compositions of botulinum toxin or botulinum neur does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of botulinum toxin or botulinum neur, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of botulinum toxin or botulinum neur will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960159